Unknown PHASE3 INTERVENTIONAL 2-arm NCT06128694

Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients

The Effect of Oral Nutrition Supplement Formulas (ONS) and Diet Counseling on Improvement of Nutritional Status, Knowledge, Attitudes, and Behavior of Cancer Patients

Sponsor: Kalbe International Pte. Ltd

Conditions Cancer Cervix Cancer, Lung Malnutrition; Protein

Interventions NUTRICAN

Updated 5 times since 2023 Last updated: Jul 28, 2024 Started: Aug 1, 2023 Primary completion: Nov 1, 2023 Completion: Aug 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Cancer Cervix and Cancer, Lung and is currently ongoing. Kalbe International Pte. Ltd leads this study, which shows 5 recorded versions since 2023 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Jan 2026 — Present [monthly]

Unknown PHASE3

Status: Recruiting → Unknown
Sep 2024 — Jan 2026 [monthly]

Recruiting PHASE3
Aug 2024 — Sep 2024 [monthly]

Recruiting PHASE3
Jul 2024 — Aug 2024 [monthly]

Recruiting PHASE3
Dec 2023 — Jul 2024 [monthly]

Recruiting PHASE3

First recorded

Aug 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kalbe International Pte. Ltd
Persahabatan Hospital

Data source: Kalbe International Pte. Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jakarta, Indonesia